uterine fibroids
Conditions
Interventions
Group 1 :Oral mifepristone for 3 months
Group 2:No
Sponsors
Affiliated Hospital of North Sichuan Medical College
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. Premenopausal patients aged 20-50 years old diagnosed as uterine fibroids by Western medicine; 2. Transvaginal color Doppler ultrasonography showed that the largest fibroid diameter was about 5-12 cm; 3. Menstrual changes, frequent urination, urgency, low back pain, backache, anemia, infertility and other clinical symptoms; 4. Intention of non-invasive treatment; 5. Haifu successfully positioned itself; 6. Those who have follow-up conditions; 7. Patients themselves voluntarily participate in this study.
Exclusion criteria
Exclusion criteria: 1. Taking or using estrogen and progesterone in the past 3 months; 2. Patients with mifepristone contraindications and drug allergies; 3. Patients with heart, lung, liver, kidney and other important organ dysfunction; 4. People with mental illness who cannot cooperate; 5. Patients with fibroid degeneration, cervical, endometrial, and ovarian malignancies; 6. Subacute or acute attack of chronic pelvic inflammatory disease, acute pelvic inflammatory disease; 7. Others who are not suitable for Haifu treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diameter and volume of myoma;Uterine blood flow resistance;Effective rate of clinical symptoms improvement; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum estrogen concentration;Progesterone concentration;Follicle stimulating hormone concentration; | — |
Countries
China
Contacts
Public ContactZeng Yuhua
North Sichuan Medical College
Outcome results
None listed